Keith G. LeBlanc, Jr, MD

Quick facts

Marketed products

• Timolol 0.25% Ophthalmic Solution · Ophthalmology
  Timolol is a non-selective beta-adrenergic receptor antagonist that reduces intraocular pressure by decreasing aqueous humor production in the eye.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Keith G. LeBlanc, Jr, MD portfolio CI brief
• Keith G. LeBlanc, Jr, MD pipeline updates RSS